These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7581411)

  • 1. Mutations in the estrogen receptor gene.
    Sluyser M
    Hum Mutat; 1995; 6(2):97-103. PubMed ID: 7581411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone resistance in cancer: the role of abnormal steroid receptors.
    Sluyser M
    Crit Rev Oncog; 1994; 5(6):539-54. PubMed ID: 8519810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines.
    Esworthy RS; Baker MA; Chu FF
    Cancer Res; 1995 Feb; 55(4):957-62. PubMed ID: 7850813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor mutations in breast cancer.
    Fuqua SA; Chamness GC; McGuire WL
    J Cell Biochem; 1993 Feb; 51(2):135-9. PubMed ID: 8440747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of normal and abnormal oestrogen receptor in breast cancer.
    McGuire WL; Chamness GC; Fuqua SA
    Cancer Surv; 1992; 14():31-40. PubMed ID: 1423328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
    Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
    Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
    Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
    deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL
    Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
    Zhang QX; Borg A; Fuqua SA
    Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW; Jazaeri AA; Shupnik MA
    Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].
    Iwase H; Kobayashi S; Iwata H; Yamashita T; Ito K; Toyama T; Hara Y; Greenman J; Mathew CG
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():61-5. PubMed ID: 8702313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
    Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
    Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.